Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
American Vanguard Corp
AVD
$64.6M
| $9.18M | 0.01% |
595,852
+46,637
| +8% | +$712K |
|
1477
Associated Banc-Corp
ASB
$6.07B
| $9.17M | 0.01% |
433,631
+373,531
| +622% | +$8.11M |
|
1478
OSI Systems
OSIS
$3.8B
| $9.16M | 0.01% |
81,308
+64,600
| +387% | +$6.51M |
|
1479
STMicroelectronics
STM
$48.6B
| $9.16M | 0.01% |
515,925
-236,499
| -31% | -$4M |
|
1480
Inseego
INSG
$78M
| $9.15M | 0.01% |
191,110
-44,770
| -19% | -$2.11M |
|
1481
CNB Financial Corp
CCNE
$1.03B
| $9.11M | 0.01% |
322,702
+3,102
| +1% | +$83.4K |
|
1482
NVE Corp
NVEC
$571M
| $9.11M | 0.01% |
130,877
+15,977
| +14% | +$1.33M |
|
|
BRFS
1483
DELISTED
BRF SA
BRFS
| $9.08M | 0.01% |
+1,194,860
| New | +$8.65M |
|
|
WAAS
1484
DELISTED
AquaVenture Holdings Limited
WAAS
| $9.08M | 0.01% |
454,500
+10,300
| +2% | +$196K |
|
1485
Teekay Tankers
TNK
$2.88B
| $9.04M | 0.01% |
883,202
+283,425
| +47% | +$2.58M |
|
|
SVM
1486
Silvercorp Metals
SVM
$2.61B
| $9.03M | 0.01% |
3,669,510
+735,100
| +25% | +$1.69M |
|
1487
Lennox International
LII
$14.4B
| $9.02M | 0.01% |
32,800
-89,800
| -73% | -$24.5M |
|
1488
First Financial Bancorp
FFBC
$3.59B
| $9.01M | 0.01% |
372,080
-81,000
| -18% | -$1.95M |
|
1489
Smith & Nephew
SNN
$12.6B
| $9.01M | 0.01% |
206,850
-13,800
| -6% | -$571K |
|
|
EXTN
1490
DELISTED
Exterran Corporation
EXTN
| $8.99M | 0.01% |
632,100
+438,500
| +226% | +$6.43M |
|
|
BELFB
1491
Bel Fuse Inc Class B
BELFB
$4.19B
| $8.92M | 0.01% |
519,439
-2,784
| -0.5% | -$58.8K |
|
1492
Home Bancorp
HBCP
$570M
| $8.9M | 0.01% |
231,400
+4,700
| +2% | +$170K |
|
|
GTS
1493
DELISTED
Triple-S Management Corporation
GTS
| $8.89M | 0.01% |
391,748
+46,985
| +14% | +$1.07M |
|
1494
Garrett Motion
GTX
$5.4B
| $8.88M | 0.01% |
+578,400
| New | +$9.82M |
|
1495
Natural Gas Services Group
NGS
$475M
| $8.86M | 0.01% |
537,005
+54,000
| +11% | +$885K |
|
1496
Korn Ferry
KFY
$4.33B
| $8.84M | 0.01% |
+220,500
| New | +$10M |
|
1497
Primis Financial Corp
FRST
$413M
| $8.83M | 0.01% |
576,813
+11,900
| +2% | +$175K |
|
|
SEMG
1498
DELISTED
SEMGROUP CORPORATION
SEMG
| $8.83M | 0.01% |
735,657
+133,500
| +22% | +$1.77M |
|
1499
Blue Bird Corp
BLBD
$2.06B
| $8.82M | 0.01% |
448,100
-19,800
| -4% | -$363K |
|
|
NVTA
1500
DELISTED
Invitae Corporation
NVTA
| $8.8M | 0.01% |
374,382
-120,171
| -24% | -$2.56M |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.